Eye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position [Yahoo! Finance]
Bausch + Lomb Corporation (BLCO)
Company Research
Source: Yahoo! Finance
On February 17, 2026, Caspian Capital disclosed a purchase of 1,349,043 shares of Bausch + Lomb Corporation (NYSE:BLCO) , an estimated $21.39 million trade based on quarterly average pricing. What happened According to its SEC filing dated February 17, 2026, Caspian Capital increased its position in Bausch + Lomb Corporation by 1,349,043 shares. The estimated transaction value was $21.39 million, calculated using the average closing price for the quarter. The quarter-end value of the position increased by $21.61 million, which includes the effects of both the share purchase and stock price movement. What else to know CASPIAN CAPITAL LP increased its Bausch + Lomb Corporation stake, which now represents 22.58% of 13F reportable AUM Top holdings after the filing: NYSE: BLCO: $34.14 million (22.6% of AUM) NASDAQ: FIP: $24.02 million (15.9% of AUM) NASDAQ: FTAI: $21.94 million (14.5% of AUM) NYSE: CCO: $20.50 million (13.6% of AUM) NYSE: PACS: $14.63 million (9.7% of
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation news events
Weekly update
A roundup of the hottest topics
BLCO
News
- 3 Reasons BLCO is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios Transcript [Seeking Alpha]Seeking Alpha
- Ophthalmic Diagnostic Devices Market Size to Hit USD 5.22 Billion by 2035 Due to Growing Demand for Early Eye Disease Detection – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma [Yahoo! Finance]Yahoo! Finance
BLCO
Earnings
- 2/18/26 - Miss
BLCO
Sec Filings
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- BLCO's page on the SEC website